Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.

Breast cancer research and treatment - 1 Feb 2018

Nilsson Martin P, Törngren Therese, Henriksson Karin, Kristoffersson Ulf, Kvist Anders, Silfverberg Barbro, Borg Åke, Loman Niklas

Abstract excerpt

PURPOSE: To evaluate a simplified method of pre-test information and germline BRCA1/2 mutation testing. METHODS: In a prospective, single-arm study, comprehensive BRCA1/2 testing was offered to unselected patients with newly diagnosed breast cancer at three hospitals in south Sweden (BRCAsearch, ClinicalTrials.gov Identifier: NCT02557776). Pre-test information was provided by a standardized invitation letter, but...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Feasibility Studies

Share to Genetic Counseling

Share to Germ-Line Mutation

Share to Patient Acceptance of Health Care

Share to Sweden

Source

Open in PubMed Open full text

Identifiers

PMID: 29164420
DOI: 10.1007/s10549-017-4584-y
PMCID: PMC5847037

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.PMID 29164420Read ↗

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.Semantic proximity Read ↗

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial.Semantic proximity Read ↗

Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake.Semantic proximity Read ↗

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialSemantic proximity Read ↗

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: Evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathwaySemantic proximity Read ↗

Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast CancerSemantic proximity Read ↗

Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?Semantic proximity Read ↗

BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications.Semantic proximity Read ↗

Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study.Semantic proximity Read ↗

Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations.Semantic proximity Read ↗

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.Semantic proximity Read ↗

A systematic review and meta-analysis of telephone vs in-person genetic counseling in BRCA1/BRCA2 genetic testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.